Vivo Capital, LLC
Vivo Capital, LLC reported 50 positions worth $908.7M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: PRAX (8.7%). Biggest move: exit SVA ($38.2M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | PRAX | $79.0M | 8.69% | 271,116 | — | — | +6.5% | |
| ▸ 2 | TRVI | $60.6M | 6.67% | 4,229,683 | — | — | -7.2% | |
| ▸ 3 | ERAS | $58.9M | 6.49% | 4,020,619 | — | — | — | |
| ▸ 4 | AVBP | $54.1M | 5.96% | 1,787,104 | — | — | -57.0% | |
| ▸ 5 | ABVX | $41.1M | 4.52% | 414,899 | — | — | — | |
| ▸ 6 | ENTX | $35.7M | 3.92% | 12,254,901 | — | — | +2.7% | |
| ▸ 7 | ACRS | $35.2M | 3.88% | 6,694,637 | — | — | -28.9% | |
| ▸ 8 | ANRO | $34.7M | 3.82% | 1,359,915 | — | — | +6.2% | |
| ▸ 9 | TNGX | $34.4M | 3.79% | 1,379,769 | — | — | -3.1% | |
| ▸ 10 | CRVS | $32.3M | 3.56% | 2,805,816 | — | — | -8.0% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Vivo Capital, LLC hold as of Q3 2026?
Vivo Capital, LLC reported 50 positions worth $908.7M in its Q3 2026 13F filing. Largest positions: PRAX (8.7%), TRVI (6.7%), ERAS (6.5%), AVBP (6.0%) and ABVX (4.5%).
What did Vivo Capital, LLC buy in Q3 2026?
New positions: ENTX, KRSA, Blossomhill Therapeutics Inc, VOR and Cue Biopharma Inc (8 in all). Added to: CAMP, ANRO, FTH, AVBP and InMed Pharmaceuticals Inc.
What did Vivo Capital, LLC sell in Q3 2026?
Reduced: DYN, ORIC, TRVI, DRUG and CMPX (8 in all). Sold out entirely: SVA, DNTH, GERN, ALXO and UNCY.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.